Wave Life Sciences Ltd stock is traded at $2.87, with a volume of 2,317,198. It is down -8.31% in the last 24 hours and down -8.31% over the past month. WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Previous Close:
$3.13
Open:
$3.08
24h Volume:
2,317,198
Relative Volume:
0.81
Market Cap:
$566.05M
Revenue:
$71.80M
Net Income/Loss:
-$183.59M
P/E Ratio:
-
EPS:
-$1.05
Net Cash Flow:
-$186.52M
1W Performance:
-17.53%
1M Performance:
-8.31%
6M Performance:
-57.61%
1Y Performance:
-59.46%
1-Day Range:
$2.86$3.15
1-Week Range:
$2.86$3.53
52-Week Range:
$2.86$21.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Name
Wave Life Sciences LtdSector
HealthcareIndustry
BiotechnologyPhone
617-949-2900Address
7 STRAITS VIEW, SINGAPORE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS